Literature DB >> 16492844

The effects of tramadol and fentanyl on gastrointestinal motility in septic rats.

Ismet Topcu1, N Zeynep Ekici, Rusen Isik, Melek Sakarya.   

Abstract

In this study, we investigated the effects of tramadol and fentanyl on gastrointestinal transit (GIT) during acute systemic inflammation in an experimental model of cecal ligation and perforation (CLP). One-hundred-twenty male Swiss-Albino rats were divided randomly into 6 groups: Group I = sham-operated + saline; Group II = sham-operated + fentanyl; Group III = sham-operated + tramadol; Group IV = CLP + saline; Group V = CLP + fentanyl; Group VI = CLP + tramadol. Suspension of charcoal was administered as an intragastric meal to measure the GIT. GIT% (mean +/- sd) were 46.1% +/- 9.8%, 43.2% +/- 9.8%, 45.9% +/- 10.2%, 33.2% +/- 9.2%, 24.9% +/- 4.1%, and 31.8% +/- 8.4% in Groups I, II, III, IV, V, and VI, respectively. GIT% was significantly less in Group V than in Groups I, II, III, and IV (P < 0.05). The Group VI mean value was significantly lower than those of Groups I, II, and III (P < 0.05) but not different from those of Groups IV and V (P > 0.05). The antitransit effect of fentanyl was shown to have increased in the experimental sepsis model, but no decrease in GIT was obtained with tramadol. This was thought to be the result of an associated endogenic opioid system activation and receptor upregulation in sepsis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16492844     DOI: 10.1213/01.ane.0000196506.28780.94

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  9 in total

Review 1.  Modeling sepsis in the laboratory: merging sound science with animal well-being.

Authors:  Jean A Nemzek; Kelly M S Hugunin; Mark R Opp
Journal:  Comp Med       Date:  2008-04       Impact factor: 0.982

2.  Endoscopically assisted water perfusion esophageal manometry with minimal sedation: technique, indications, and implication on the clinical management.

Authors:  Rita Brun; Kyle Staller; Sofia Viner; Braden Kuo
Journal:  J Clin Gastroenterol       Date:  2011-10       Impact factor: 3.062

3.  Analgesic Efficacy and Safety of Hydromorphone in Chinchillas (Chinchilla lanigera).

Authors:  Emily A Evenson; Christoph Mans
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-05-01       Impact factor: 1.232

Review 4.  The role of experimental models in developing new treatments for irritable bowel syndrome.

Authors:  Daniel P Holschneider; Sylvie Bradesi; Emeran A Mayer
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 3.869

Review 5.  To Treat or Not to Treat: The Effects of Pain on Experimental Parameters.

Authors:  Norman C Peterson; Elizabeth A Nunamaker; Patricia V Turner
Journal:  Comp Med       Date:  2017-12-01       Impact factor: 0.982

Review 6.  Functional GI disorders: from animal models to drug development.

Authors:  E A Mayer; S Bradesi; L Chang; B M R Spiegel; J A Bueller; B D Naliboff
Journal:  Gut       Date:  2007-10-26       Impact factor: 23.059

7.  Analgesic opioid dose is an important indicator of postoperative ileus following radical cystectomy with ileal conduit: experience in the robotic surgery era.

Authors:  Kyo Chul Koo; Young Eun Yoon; Byung Ha Chung; Sung Joon Hong; Koon Ho Rha
Journal:  Yonsei Med J       Date:  2014-09       Impact factor: 2.759

8.  Comparison of In Vitro Effects of Opioid Analgesics on Spontaneous Proximal and Distal Colon Contractions in Healthy Rats and Rats with Peritonitis.

Authors:  İdris Erşan; Sinan Gürsoy; Onur Avcı; Ahmet Altun; İhsan Bağcıvan; Cevdet Düger; İclal Özdemir Kol; Kenan Kaygusuz; Mehmet Caner Mimaroğlu
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-06-01

Review 9.  Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives.

Authors:  Marta Sobczak; Maciej Sałaga; Martin A Storr; Jakub Fichna
Journal:  J Gastroenterol       Date:  2013-02-09       Impact factor: 7.527

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.